Search All US Patents
Patent | Abstract |
---|---|
Glyphomicins A and B
Patent number: 4842857 Assignee: E. R. Squibb And Sons, Inc. (Princeton, NJ) Inventors: Edward Meyers (East Brunswick, NJ), William L. Parker (Pennington, NJ) |
Cultivation of a strain of the microorganism Micromonospora sp. A.T.C.C. No. 53481, yields the novel antibiotic substance glyphomicin, which is a mixture of glyphomicin A and glyphomicin B. |
10'-Desmethoxystreptonigrin
Patent number: 5158960 Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ) Inventors: Edward Meyers (East Brunswick, NJ), Terrence W. Doyle (Killingworth, CT), Veeraswamy Manne (Yardley, PA), Wen-Chih Liu (Princeton Junction, NJ) |
10'-Desmethoxystreptonigrin, obtainable by cultivation of a strain of Streptomyces albus, A.T.C.C. No. 55161, and salts, esters and amides thereof. The novel compounds have antitumor and antibiotic activity. |
10'desmethoxystreptonigrin production by Streptomyces albus
Patent number: 5320955 Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ) Inventors: Edward Meyers (East Brunswick, NJ), Terrence W. Doyle (Killingworth, CT), Veeraswamy Manne (Yardley, PA), Wen-Chih Liu (Princeton Junction, NJ) |
10'-Desmethoxystreptonigrin, obtainable by cultivation of a strain of Streptomyces albus, A.T.C.C. No. 55161, and salts, esters and amides thereof. The novel compounds have antitumor and antibiotic activity. |
Antibiotic produced by Bacillus subtilis ATCC 55422 capable of inhibiting bacteria
Patent number: 5364623 Assignee: Bristol Myers Squibb Company (Princeton, NJ) Inventors: Pramathesh S. Patel (Ringoes, NJ), Friedrich Mayerl (Norwalk, CT), Edward Meyers (East Brunswick, NJ) |
The invention is drawn to an antibiotic produced by Bacillus subtilis ATCC 55422 having a nominal molecular weight of 580 and the empirical formula C.sub.35 H.sub.48 O.sub.7, or a salt thereof. The antibiotic is useful in inhibiting the growth of bacteria, including Escherichia, Klebsiella, Proteus, Serratia, Bacillus and Staphylococcus. |
Antibiotics xylocandin A and xylocandin B
Patent number: 4601904 Assignee: E. R. Squibb & Sons, Inc. (Princeton, NJ) Inventors: Edward Meyers (East Brunswick, NJ), Wen-Chih Liu (Princeton Junction, NJ), Richard B. Sykes (Belle Mead, NJ) |
Cultivation of a strain of the microorganism Pseudomonas cepacia which has been deposited in the American Type Culture Collection as A.T.C.C. No. 39277, yields novel antibiotic substances xylocandin A and xylocandin B having activity against yeasts and fungi. |